Details for New Drug Application (NDA): 019194
✉ Email this page to a colleague
NDA 019194 describes SYPRINE, which is a drug marketed by Bausch and is included in one NDA. It is available from one supplier. Additional details are available on the SYPRINE profile page.
The generic ingredient in SYPRINE is trientine hydrochloride. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
The generic ingredient in SYPRINE is trientine hydrochloride. There are ten drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the trientine hydrochloride profile page.
Summary for 019194
| Tradename: | SYPRINE |
| Applicant: | Bausch |
| Ingredient: | trientine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 019194
| Mechanism of Action | Metal Chelating Activity |
Medical Subject Heading (MeSH) Categories for 019194
Suppliers and Packaging for NDA: 019194
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| SYPRINE | trientine hydrochloride | CAPSULE;ORAL | 019194 | NDA | Bausch Health US LLC | 0187-2120 | 0187-2120-10 | 1 BOTTLE in 1 CARTON (0187-2120-10) / 100 CAPSULE in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
| Approval Date: | Nov 8, 1985 | TE: | AB | RLD: | Yes | ||||
Complete Access Available with Subscription
